SCHEDULE 13D Filed 2026-11-02 Event 2026-11-02 SEC 0001373604-26-000071 →

BML Investment Partners, L.P. → Seer, Inc. SEER

Stake: 4.70% Shares: 2,180,490 CUSIP: 81578P106 Class: Common Stock

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 14/100 · Filer 90d Win Rate: 0% · Hist. 90d Edge: +0.0%

Item 4 — Purpose of Transaction

On November 2, the Reporting Person sent a letter to the Board expressing disappointment in the Board's decision to remain a public company.

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

2 13D/G filings on this issuer

1 other filing besides this one

Filer Track Record

8 filings by this filer

7 other filings in the data moat

Short Interest · settle 2026-10-15

DTC 1.00

94,400 shares short · -13.1% vs prior

Held by elite portfolio managers

1 holder · $55K

Point72 Asset Mgmt

Filed	Form	Filer	Stake	Shares
2021-11-17	SC	MAVERICK CAPITAL MANAGEMENT LLC	—	—	view →

Filed	Form	Issuer	Stake	Shares
2026-10-06	SCHEDULE 13G	Connect Biopharma Holdings Ltd	—	—	view →
2026-06-29	SCHEDULE 13G/A	ORAMED PHARMACEUTICALS INC. ORMP	—	—	view →
2025-03-05	SCHEDULE	Aadi Bioscience, Inc. WHWK	4.98%	2,435,000	view →
2025-02-24	SCHEDULE	Aadi Bioscience, Inc. WHWK	9.90%	2,435,000	view →
2025-02-04	SCHEDULE	Aadi Bioscience, Inc. WHWK	9.90%	2,435,000	view →
2024-01-11	SC	Forte Biosciences, Inc. FBRX	—	—	view →
2022-07-07	SC	Forte Biosciences, Inc. FBRX	—	—	view →

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.